New study checks if cancer immunotherapy harms the heart
NCT ID NCT06332131
First seen Feb 12, 2026 · Last updated May 25, 2026 · Updated 22 times
Summary
This study looks at how immune checkpoint inhibitors, a type of immunotherapy for cancer, affect the tiny blood vessels in the heart. Researchers will use heart scans and blood tests in 25 adults with breast or lung cancer before and during treatment. The goal is to understand if these drugs cause heart problems, not to treat them.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Abramson Cancer Center at University of Pennsylvania
Philadelphia, Pennsylvania, 19104, United States
Conditions
Explore the condition pages connected to this study.